PALYNZIQ

Serial Number 87095019
Registration 5581302
702

Registration Progress

Application Filed
Jul 6, 2016
Under Examination
Jan 24, 2017
Approved for Publication
Nov 29, 2016
Published for Opposition
Nov 29, 2016
Registered
Oct 9, 2018

Trademark Image

PALYNZIQ

Basic Information

Serial Number
87095019
Registration Number
5581302
Filing Date
July 6, 2016
Registration Date
October 9, 2018
Published for Opposition
November 29, 2016
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Dec 31, 2024
Registration
Registered
Classes
005

Rights Holder

Biomarin Pharmaceutical Inc.

03
Address
105 Digital Drive
Novato, CA 94949

Ownership History

Biomarin Pharmaceutical Inc.

Original Applicant
03
Novato, CA

Biomarin Pharmaceutical Inc.

Owner at Publication
03
Novato, CA

Biomarin Pharmaceutical Inc.

Original Registrant
03
Novato, CA

Legal Representation

Attorney
Gregory J. Chinlund

USPTO Deadlines

Next Deadline
1161 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-10-09)
Due Date
October 09, 2028
Grace Period Ends
April 09, 2029

Application History

33 events
Date Code Type Description Documents
Dec 31, 2024 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Dec 31, 2024 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Dec 30, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jul 30, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Oct 9, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Dec 9, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 9, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Dec 9, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 9, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 9, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 7, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 6, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 20, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 20, 2018 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 23, 2018 IUAF S USE AMENDMENT FILED Loading...
Jul 23, 2018 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 23, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 20, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 18, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 18, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 18, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 12, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 10, 2017 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 10, 2017 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 10, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 24, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 29, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 29, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 9, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 17, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 14, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 12, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 9, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for use in enzyme therapy
First Use Anywhere: Jul 2, 2018
First Use in Commerce: Jul 2, 2018

Classification

International Classes
005